Immune profile of head and neck squamous cell carcinoma (HNSCC) patients can be used to assessment of radiotherapy response: transcriptome-based analysis

被引：0
|
作者：
Teresiak, A. [1 ,2 ]
Kolenda, T. [1 ,2 ]
Braska, A. [1 ]
Kozlowska-Maslon, J. [1 ,2 ]
Mantaj, P. [4 ]
Grzejda, N. [1 ,3 ]
Guglas, K. [1 ,2 ]
Poter, P. [5 ]
Dudek, K. [1 ,6 ]
Regulska, K. [7 ]
Blizniak, R. [1 ]
Kazimierczak, U. [8 ]
Lamperska, K. [1 ,2 ]
机构：
[1] Greater Poland Canc Ctr, Canc Genet Lab, 15 Garbary St, PL-61866 Poznan, Poland
[2] Greater Poland Canc Ctr, Res & Implementat Unit, Garbary St, PL-61866 Poznan, Poland
[3] Adam Mickiewicz Univ, Inst Human Biol & Evolut, Fac Biol, Uniwersytetu Poznanskiego 6, PL-61614 Poznan, Poland
[4] Greater Poland Canc Ctr, Radiat Protect Dept, Garbary St 15, PL-61866 Poznan, Poland
[5] Greater Poland Canc Ctr, Dept Tumor Pathol, Garbary St, PL-61866 Poznan, Poland
[6] Poznan Univ Life Sci, Wojska Polskiego 28, PL-60637 Poznan, Poland
[7] Pharm Greater Poland Canc Ctr, Garbary St 15, PL-61866 Poznan, Poland
[8] Poznan Univ Med Sci, Chair Med Biotechnol, Dept Canc Immunol, 8 Rokietnicka St, PL-60806 Poznan, Poland
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-092
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [21] Assessment of immune suppressive circuits in the tumour micro-environment of human head and neck squamous cell carcinoma (HNSCC)
    Rivals, J. P.
    Cesson, V.
    Rimoldi, D.
    Seelentag, W.
    Speiser, D.
    Romero, P.
    Monnier, P.
    Bron, L.
    SWISS MEDICAL WEEKLY, 2008, 138 : 58S - 58S
  • [22] Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Weller, Patrick
    Nel, Ivonne
    Hassenkamp, Philipp
    Gauler, Thomas
    Schlueter, Anke
    Lang, Stephan
    Dountsop, Paulette
    Hoffmann, Andreas-Claudius
    Lehnerdt, Goetz
    PLOS ONE, 2014, 9 (12):
  • [23] Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis
    Bourhis, J
    Audry, H
    Overgaard, J
    Ang, K
    Dische, S
    Horiot, J
    Hliniak, A
    O'Sullivan, B
    Dobrowsky, W
    Skladowski, K
    Fallai, C
    Hay, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S190 - S191
  • [24] Prognostic impact of comorbidity in elderly patients with head and neck squamous cell carcinoma (HNSCC)
    Moreno Jimenez, M. A.
    Gonzalez Cebrian, I.
    Collado Martin, R.
    Medina Magan, B.
    Ortega Granados, A. L.
    Mateos Salido, M. J.
    Alonso Calderon, R.
    Plata, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [25] Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC)
    Overgaard, Jens
    Alsner, Jan
    RADIOTHERAPY AND ONCOLOGY, 2019, 130 : 191 - 192
  • [26] Assessment of toxicity and the factors limiting concomitant radiochemotherapy in squamous cell carcinoma of head and neck (HNSCC)
    Atasoy, B.
    Dane, F.
    Ozen, Z.
    Akgun, Z.
    Yumuk, F.
    Abacioglu, U.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S49 - S49
  • [27] Prediction of neck dissection (ND) requirement following definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC)
    Thariat, J.
    Ahamad, A.
    Garden, A. S.
    Allen, P. K.
    Morrison, W. H.
    Rosenthal, D.
    Weber, R. S.
    Ginsberg, L. E.
    El-Naggar, A. K.
    Ang, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S17 - S18
  • [28] Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).
    Alfieri, Salvatore
    Ferrara, Roberto
    Calareso, Giuseppina
    Cavalieri, Stefano
    Platini, Francesca
    Mancinelli, Moela
    Resteghini, Carlo
    Orlandi, Ester
    Iacovelli, Nicola Alessandro
    Ferella, Letizia
    Piazza, Cesare
    Apollonio, Giulia
    Galbiati, Donata
    Bossi, Paolo
    Bergamini, Cristiana
    Locati, Laura Deborah
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature
    Zhu, Guang-Li
    Yang, Kai-Bin
    Xu, Cheng
    Feng, Rui-Jia
    Li, Wen-Fei
    Ma, Jun
    CANCER MEDICINE, 2022, 11 (23): : 4673 - 4687
  • [30] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07): : E2413 - E2419
12345